Banka BioLoo (India) Performance
| BANKA Stock | 102.18 0.99 0.98% |
The firm shows a Beta (market volatility) of 0.66, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Banka BioLoo's returns are expected to increase less than the market. However, during the bear market, the loss of holding Banka BioLoo is expected to be smaller as well. At this point, Banka BioLoo Limited has a negative expected return of -0.15%. Please make sure to confirm Banka BioLoo's maximum drawdown, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to decide if Banka BioLoo Limited performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Banka BioLoo Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors. ...more
Last Split Factor 5:2 | Ex Dividend Date 2020-09-08 | Last Split Date 2020-09-08 |
1 | Lumax Auto Tech jumps after inking pact to acquire GreenFuel Energy - Business Standard | 11/14/2024 |
2 | Banka Bioloo Consolidated September 2024 Net Sales at Rs 12.41 crore, up 8. percent Y-o-Y - Moneycontrol | 12/05/2024 |
| Begin Period Cash Flow | 8.4 M |
Banka |
Banka BioLoo Relative Risk vs. Return Landscape
If you would invest 11,547 in Banka BioLoo Limited on September 26, 2024 and sell it today you would lose (1,329) from holding Banka BioLoo Limited or give up 11.51% of portfolio value over 90 days. Banka BioLoo Limited is generating negative expected returns and assumes 3.0447% volatility on return distribution over the 90 days horizon. Simply put, 27% of stocks are less volatile than Banka, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Banka BioLoo Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Banka BioLoo's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Banka BioLoo Limited, and traders can use it to determine the average amount a Banka BioLoo's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0499
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BANKA |
Estimated Market Risk
| 3.04 actual daily | 27 73% of assets are more volatile |
Expected Return
| -0.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Banka BioLoo is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Banka BioLoo by adding Banka BioLoo to a well-diversified portfolio.
Banka BioLoo Fundamentals Growth
Banka Stock prices reflect investors' perceptions of the future prospects and financial health of Banka BioLoo, and Banka BioLoo fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Banka Stock performance.
| Return On Equity | -0.0168 | ||||
| Return On Asset | 0.0136 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 1.28 B | ||||
| Shares Outstanding | 10.85 M | ||||
| Price To Book | 3.22 X | ||||
| Price To Sales | 2.06 X | ||||
| Revenue | 499.96 M | ||||
| Gross Profit | 130.15 M | ||||
| EBITDA | 41.85 M | ||||
| Net Income | (6.53 M) | ||||
| Cash And Equivalents | 17.45 M | ||||
| Total Debt | 259.13 M | ||||
| Book Value Per Share | 36.62 X | ||||
| Cash Flow From Operations | 9.43 M | ||||
| Earnings Per Share | (4.95) X | ||||
| Total Asset | 774.23 M | ||||
| Retained Earnings | 200.75 M | ||||
About Banka BioLoo Performance
By examining Banka BioLoo's fundamental ratios, stakeholders can obtain critical insights into Banka BioLoo's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Banka BioLoo is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Banka BioLoo is entity of India. It is traded as Stock on NSE exchange.Things to note about Banka BioLoo Limited performance evaluation
Checking the ongoing alerts about Banka BioLoo for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Banka BioLoo Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Banka BioLoo Limited generated a negative expected return over the last 90 days | |
| Banka BioLoo Limited has high historical volatility and very poor performance | |
| The company reported the revenue of 499.96 M. Net Loss for the year was (6.53 M) with profit before overhead, payroll, taxes, and interest of 130.15 M. | |
| Latest headline from news.google.com: Banka Bioloo Consolidated September 2024 Net Sales at Rs 12.41 crore, up 8. percent Y-o-Y - Moneycontrol |
- Analyzing Banka BioLoo's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Banka BioLoo's stock is overvalued or undervalued compared to its peers.
- Examining Banka BioLoo's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Banka BioLoo's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Banka BioLoo's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Banka BioLoo's stock. These opinions can provide insight into Banka BioLoo's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Banka Stock
Banka BioLoo financial ratios help investors to determine whether Banka Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Banka with respect to the benefits of owning Banka BioLoo security.